Abstract Details
|
Ioannis Karakis, MD, FAAN
(Emory University)
PRESENTER |
Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson. |
| Santiago Flesler | Santiago Flesler has nothing to disclose. |
| Meng Han Tsai, MD | Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for GSK. The institution of Dr. Tsai has received research support from National Heath Research Institute. The institution of Dr. Tsai has received research support from National Science Technology Council. |
| Ovi Ghorpade | No disclosure on file |
| Rio Carla Pineda (GSK) | No disclosure on file |
| Kalpesh Joshi | No disclosure on file |
| James Cooper, PhD (GlaxoSmithKline) | Dr. Cooper has received personal compensation for serving as an employee of GSK. Dr. Cooper has stock in GSK. |
| SHILPA PATKAR | No disclosure on file |
| Andrea Schulz | No disclosure on file |
| Savita Anand (Evidera) | No disclosure on file |
| Nicola Barnes (Evidera) | No disclosure on file |